Amalgamated Bank Has $553,000 Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA)

Amalgamated Bank decreased its stake in Privia Health Group, Inc. (NASDAQ:PRVA) by 3.9% during the 3rd quarter, HoldingsChannel reports. The fund owned 30,378 shares of the company’s stock after selling 1,225 shares during the period. Amalgamated Bank’s holdings in Privia Health Group were worth $553,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of PRVA. Allspring Global Investments Holdings LLC grew its stake in shares of Privia Health Group by 9.2% in the first quarter. Allspring Global Investments Holdings LLC now owns 8,970 shares of the company’s stock worth $176,000 after acquiring an additional 756 shares during the last quarter. SG Americas Securities LLC acquired a new stake in shares of Privia Health Group in the first quarter worth $131,000. Swiss National Bank grew its stake in shares of Privia Health Group by 0.8% in the first quarter. Swiss National Bank now owns 186,400 shares of the company’s stock worth $3,652,000 after acquiring an additional 1,400 shares during the last quarter. Sei Investments Co. grew its stake in shares of Privia Health Group by 50.7% in the first quarter. Sei Investments Co. now owns 457,880 shares of the company’s stock worth $8,970,000 after acquiring an additional 154,044 shares during the last quarter. Finally, ProShare Advisors LLC grew its stake in shares of Privia Health Group by 7.5% in the first quarter. ProShare Advisors LLC now owns 22,483 shares of the company’s stock worth $440,000 after acquiring an additional 1,562 shares during the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Stock Down 2.3 %

Privia Health Group stock opened at $21.20 on Friday. The stock has a 50-day simple moving average of $18.71 and a 200 day simple moving average of $18.49. Privia Health Group, Inc. has a 12-month low of $15.92 and a 12-month high of $24.30. The stock has a market capitalization of $2.54 billion, a price-to-earnings ratio of 212.00, a P/E/G ratio of 5.07 and a beta of 0.76.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on PRVA. KeyCorp began coverage on Privia Health Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $23.00 target price for the company. Barclays raised their target price on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. Robert W. Baird raised their target price on Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, August 26th. Truist Financial raised their target price on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $28.00 target price on shares of Privia Health Group in a research report on Wednesday, August 14th. Two investment analysts have rated the stock with a hold rating, twelve have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, Privia Health Group presently has an average rating of “Buy” and a consensus price target of $25.07.

Insider Activity at Privia Health Group

In related news, CEO Parth Mehrotra sold 135,142 shares of Privia Health Group stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total value of $2,500,127.00. Following the completion of the sale, the chief executive officer now directly owns 247,771 shares in the company, valued at $4,583,763.50. This trade represents a 35.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 14.20% of the stock is currently owned by company insiders.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.